Tempest Therapeutics (TPST) Files $300M Mixed Shelf
Tweet
Share
E-mailGet Alerts TPST Hot Sheet
Join SI Premium – FREE
Tempest Therapeutics (NASDAQ: TPST) has filed $300,000,000 mixed shelf of:
Common Stock
Preferred Stock
Debt Securities
Warrants
Rights
Units
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Takeda names Julie Kim as president and CEO after shareholder vote
- Citizens Starts Bitdeer Technologies Group (BTDR) at Market Outperform
- Canaccord Starts Elixir Energy Ltd (EXR:AU) at Spec. Buy
Create E-mail Alert Related Categories
Corporate News, Equity OfferingsRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
